The Asia Pacific district has seen a striking surge in the interest for blood glucose test strips, driven by the rising frequency of diabetes. This market fragment assumes a critical part in diabetes management, empowering people to screen their blood glucose levels helpfully.
One of the essential market patterns is the heightening commonness of diabetes across the Asia Pacific district. Factors like sedentary ways of life, unhealthy dietary propensities, and genetic inclinations add to the developing diabetic population. Thus, the interest for blood glucose test strips has seen a critical rise.
Homecare settings have turned into a point of convergence for diabetes management, with a rising number of people predilection to screen their blood glucose levels in the comfort of their homes. This pattern has prodded the interest for simple to-utilize and solid blood glucose test strips.
The Asia Pacific Blood Glucose Test Strip market is seeing expanded rivalry among central participants. Market combination exercises, like consolidations and acquisitions, are predominant as organizations endeavor to improve their item portfolios and extend their geographic reach.
Openness and rationality remain key contemplations in the Asia Pacific area. Market players are focusing in on creating practical arrangements without settling on quality, making blood glucose test strips more open to a more extensive portion of the population.
Adherence to rigid administrative norms and quality prerequisites is gaining conspicuousness in the Asia Pacific Blood Glucose Test Strip market. Administrative bodies are effectively associated with guaranteeing the security and viability of these items, imparting trust in both healthcare suppliers and end-clients.
Asia Pacific Blood Glucose Test Strip Market Size was valued at USD 2.03 Billion in 2023. The Global Asia Pacific Blood Glucose Test Strip industry is projected to grow from USD 2.14 Billion in 2024 to USD 3.17 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.98% during the forecast period (2024 - 2032). Diabetes a metabolic condition that occurs due to insufficient production of insulin. Blood glucose monitoring is a routine procedure for monitoring the glucose level. Blood glucose strip market is continuously growing in the Asia pacific region. These devices monitor the glucose level in the blood. Different types of strips are available in the market having impregnate of glucose oxidase, glucose dehydrogenase and other type of enzymes. When blood comes in the contact with this enzymes, they react with the glucose in the blood and indicates the blood glucose level. Advances and development in the technology has introduced the number of different devices in the market. The major driving factor for the Asia Pacific blood glucose test strip market is continuously increasing diabetes population. Diabetic population is constantly increasing and glucose level monitoring is an important part of diagnosis and treatment of diabetes. Patient with diseases, for instance, diabetes can now live longer and healthier life due to continuously monitoring of disease. Additionally, increasing awareness about preventive care of various diseases, rising obese population, and changing lifestyle boosting the growth of the Asia Pacific blood glucose test strip market. However, lack of accuracy and relatively high chances of false positive results may slow the growth of the Asia Pacific blood glucose test strip market.Figure- Asia Pacific blood glucose test strip market, by types
Source- World Health Organization (WHO, white paper, company presentation, annual report
Key Players Some of the major key players in the Asia Pacific blood glucose test strip market are F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), LifeScan, Inc. (US), i-SENS. Inc. (South Korea), AgaMatrix (US), TaiDoc Technology Corporation (Taiwan), BioSensors, Inc. (US), Universal Biosensors (Australia), Beijing Yicheng Electronic Co., Ltd (China), Hmd Biomedical (Taiwan), and B. Braun Melsungen Ag (Germany). Segmentation
On the basis of types, the Asia Pacific blood glucose test strip market is segmented into glucose oxidase, glucose dehydrogenase, and other.
On the basis of technology, the Asia Pacific blood glucose test strip market is segmented into wicking technology and channel technology.
On the basis of end user, the Asia Pacific blood glucose test strip market is categorised in hospital, clinic, homecare and others
Regional Analysis Asia Pacific blood glucose test strip market is segmented into Japan, China, India, Australia, Republic of Korea and Rest of Asia Pacific. It is the fastest growing region in the global blood glucose strip market. The diabetic population in Asia Pacific is increasing continuously, which is the major driver the market. According to the World Health Organization (WHO), total diabetic population of India and China in 2012 was 61 million and 90 million respectively. Moreover, increasing awareness among the people, increasing healthcare expenditure and rising obese population have fuelled the growth of the market. China and India are the two major contributor to the Asia Pacific glucose test strip market owing to the presence of huge diabetic population.
Market Assessment
Source: World Health Organization (WHO, white paper, company presentation, annual report
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)